What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
about
Patients' Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments.Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide.Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.Patient preferences for the attributes of a non-invasive treatment for superficial Basal cell carcinoma: a discrete choice experiment.
P2860
What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
What determines patient prefer ...... nt survey from the SINS trial.
@ast
What determines patient prefer ...... nt survey from the SINS trial.
@en
What determines patient prefer ...... nt survey from the SINS trial.
@nl
type
label
What determines patient prefer ...... nt survey from the SINS trial.
@ast
What determines patient prefer ...... nt survey from the SINS trial.
@en
What determines patient prefer ...... nt survey from the SINS trial.
@nl
prefLabel
What determines patient prefer ...... nt survey from the SINS trial.
@ast
What determines patient prefer ...... nt survey from the SINS trial.
@en
What determines patient prefer ...... nt survey from the SINS trial.
@nl
P2860
P356
P1433
P1476
What determines patient prefer ...... nt survey from the SINS trial.
@en
P2093
Hywel C Williams
Mara Ozolins
P2860
P2888
P356
10.1186/1471-5945-12-19
P577
2012-10-04T00:00:00Z
P5875
P6179
1023230329